Today's Daily Dose brings you news about Alector's frontotemporal dementia trial results, Auris Medical's upcoming clinical trial catalyst, Denali's progress in COVID-19 trial, and disappointing results from Roche's phase III COVACTA study.
from RTT - Biotech https://ift.tt/3hLVNwf
via IFTTT
No comments:
Post a Comment